The UK Intellectual Property Office has today, July 5, opened a consultation into supplementary protection certificate law in the event of a ‘no deal’ Brexit.
The Court of Justice of the European Union has rejected a trademark appeal submitted by Virgin Islands-headquartered Viridis Pharmaceutical.
Charity Cancer Research UK has united with SV Health Investors, a venture capital and growth equity firm, to develop new cancer medicines for patients.
Reddie & Grose has appointed Robin Ellis as a partner in the firm’s Munich office.
Carpmaels & Ransford has appointed two life sciences attorneys as partners, effective yesterday, July 1.
The controversial supplementary protection certificate manufacturing waiver has come into force today, July 1.
US drug maker AbbVie has agreed to buy Allergan, the Ireland-headquartered maker of Botox, for $63 billion, in the latest blockbuster deal for the pharmaceutical industry.
Pfizer’s attempt to secure an Arrow declaration in relation to its proposed launch of a cancer drug in Europe was shot down yesterday, June 20, by the English High Court.
British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.
The EU’s General Court has upheld the European Union Intellectual Property Office’s finding that a trademark for dietary supplements was descriptive of the relevant services to an Italian speaking public.